Search research articles
Contact Us
Filters
Showing results (341-350 of 431) with videos related to
Page
of 44
Sort By:
Journal of Human Genetics
|
September 9, 2016
Identification of 15 novel partial SHOX deletions and 13 partial duplications, and a review of the literature reveals intron 3 to be a hotspot region
Sara Benito-Sanz, Alberta Belinchon-Martínez, Miriam Aza-Carmona, et al.
Journal of Neuro-Oncology
|
February 18, 2018
Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas
David S Hersh, Sen Peng, Jimena G Dancy, et al.
Talanta
|
May 6, 2010
Second interlaboratory exercise on non-steroidal anti-inflammatory drug analysis in environmental aqueous samples
E Heath, T Kosjek, M Farre, et al.
Human Mutation
|
July 22, 2017
FGF9 mutation causes craniosynostosis along with multiple synostoses
Maria Rodriguez-Zabala, Miriam Aza-Carmona, Carlos I Rivera-Pedroza, et al.
Human Molecular Genetics
|
January 26, 2011
SHOX interacts with the chondrogenic transcription factors SOX5 and SOX6 to activate the aggrecan enhancer
Miriam Aza-Carmona, Debbie J Shears, Patricia Yuste-Checa, et al.
American Journal of Medical Genetics. Part A
|
May 24, 2019
Loss of function BMP4 mutation supports the implication of the BMP/TGF-β pathway in the etiology of combined pituitary hormone deficiency
Francisco J Rodríguez-Contreras, Mercedes Marbán-Calzón, Elena Vallespín, et al.
Clinical Genetics
|
November 14, 2024
AMOTL1 -Associated Multiple Congenital Anomalies (Craniofaciocardiohepatic Syndrome, CFCHS): A Novel Clinical Spectrum Including Craniofacial, Heart and Liver Abnormalities
Natalia Gallego-Zazo, Jair Tenorio-Castano, Alejandro Parra, et al.
Journal of Pediatric Hematology/Oncology
|
December 11, 2014
Prasugrel in children with sickle cell disease: pharmacokinetic and pharmacodynamic data from an open-label, adaptive-design, dose-ranging study
Lori Styles, Darell Heiselman, Lori E Heath, et al.
Anales De Pediatria
|
November 8, 2022
Achondroplasia: Update on diagnosis, follow-up and treatment
Antonio Leiva-Gea, María F Martos Lirio, Ana Coral Barreda Bonis, et al.
Journal of Clinical Medicine
|
November 21, 2019
Geographic Differences in Phenotype and Treatment of Children with Sickle Cell Anemia from the Multinational DOVE Study
Baba Psalm Duniya Inusa, Raffaella Colombatti, David C Rees, et al.
Page
of 44
Search research articles
Search
Showing results (341-350 of 431) with videos related to
Sort By:
Page
of 44
Journal of Human Genetics
|
September 9, 2016
Identification of 15 novel partial SHOX deletions and 13 partial duplications, and a review of the literature reveals intron 3 to be a hotspot region
Sara Benito-Sanz, Alberta Belinchon-Martínez, Miriam Aza-Carmona, et al.
Journal of Neuro-Oncology
|
February 18, 2018
Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas
David S Hersh, Sen Peng, Jimena G Dancy, et al.
Talanta
|
May 6, 2010
Second interlaboratory exercise on non-steroidal anti-inflammatory drug analysis in environmental aqueous samples
E Heath, T Kosjek, M Farre, et al.
Human Mutation
|
July 22, 2017
FGF9 mutation causes craniosynostosis along with multiple synostoses
Maria Rodriguez-Zabala, Miriam Aza-Carmona, Carlos I Rivera-Pedroza, et al.
Human Molecular Genetics
|
January 26, 2011
SHOX interacts with the chondrogenic transcription factors SOX5 and SOX6 to activate the aggrecan enhancer
Miriam Aza-Carmona, Debbie J Shears, Patricia Yuste-Checa, et al.
American Journal of Medical Genetics. Part A
|
May 24, 2019
Loss of function BMP4 mutation supports the implication of the BMP/TGF-β pathway in the etiology of combined pituitary hormone deficiency
Francisco J Rodríguez-Contreras, Mercedes Marbán-Calzón, Elena Vallespín, et al.
Clinical Genetics
|
November 14, 2024
AMOTL1 -Associated Multiple Congenital Anomalies (Craniofaciocardiohepatic Syndrome, CFCHS): A Novel Clinical Spectrum Including Craniofacial, Heart and Liver Abnormalities
Natalia Gallego-Zazo, Jair Tenorio-Castano, Alejandro Parra, et al.
Journal of Pediatric Hematology/Oncology
|
December 11, 2014
Prasugrel in children with sickle cell disease: pharmacokinetic and pharmacodynamic data from an open-label, adaptive-design, dose-ranging study
Lori Styles, Darell Heiselman, Lori E Heath, et al.
Anales De Pediatria
|
November 8, 2022
Achondroplasia: Update on diagnosis, follow-up and treatment
Antonio Leiva-Gea, María F Martos Lirio, Ana Coral Barreda Bonis, et al.
Journal of Clinical Medicine
|
November 21, 2019
Geographic Differences in Phenotype and Treatment of Children with Sickle Cell Anemia from the Multinational DOVE Study
Baba Psalm Duniya Inusa, Raffaella Colombatti, David C Rees, et al.
Page
of 44